Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Penwest Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry With the Highest Operating Margin (PPCO, POZN, QCOR, VPHM, KV.A)
Smartrend
Saturday, September 18, 2010 - 12:09pm
tags:
Penwest, Questcor Pharmaceuticals, ViroPharma, KV Pharmaceutical, Pozen
SuperGen - an Underappreciated Biotech with Cash + FCF
Gurufocus
Saturday, September 18, 2010 - 12:06pm
tags:
Supergen, investors
Sanofiboard may be key to Genzyme deal
Calgary Herald, Canada
Saturday, September 18, 2010 - 11:35am
tags:
Sanofi, Genzyme, M&A
FDA reviewing safety of Actos diabetes drug
MSNBC
Saturday, September 18, 2010 - 11:28am
tags:
Actos, diabetes, Takeda
F.D.A. Postpones Rule on Breast Cancer Drug
NY Times
Saturday, September 18, 2010 - 11:27am
tags:
Avastin, Genentech
More Upside for Bristol-Myers Squibb ?
Traders Huddle
Saturday, September 18, 2010 - 11:25am
tags:
Bristol-Myers Squibb
Top 5 Upcoming FDA Decisions With Bullish Options Sentiment
Seeking Alpha
Saturday, September 18, 2010 - 11:07am
tags:
Ista, Alexza, Biodel, Alkermes, Vivus
Johnson & Johnson: More Buffett-Like Every Day
Motley Fool
Saturday, September 18, 2010 - 11:04am
tags:
JNJ, Crucell
Big Pharma Awakes From Long Slumber
Yahoo/Investor's Business Daily
Saturday, September 18, 2010 - 11:03am
tags:
Big Pharma
House probing possible second secret recall by J&J
Yahoo/AP
Saturday, September 18, 2010 - 11:02am
tags:
JNJ, recalls
FDA Pushes Out Brilinta Action Date
Yahoo/Zacks
Saturday, September 18, 2010 - 11:01am
tags:
AstraZeneca, Brilinta, acute coronary syndrome, Plavix, Bristol-Myers Squibb
Thanks for Nothing, Fen-Phen
Motley Fool
Saturday, September 18, 2010 - 10:58am
tags:
Abbott Laboratories, Meridia, Sanofi, Acomplia, Arena Pharmaceuticals
FDA panel urges wider use for Alkermes drug
Reuters
Friday, September 17, 2010 - 11:55am
tags:
FDA, advisory panels, Alkermes, addiction, Vivitrol
Sanofi board heavyweights may be key to Genzyme deal
Yahoo/Reuters
Friday, September 17, 2010 - 11:54am
tags:
M&A, Genzyme, Sanofi
$1,000 a Pop: How Forest Labs Bribed Doctors to Prescribe Antidepressants to Kids
BNET Pharma
Friday, September 17, 2010 - 11:50am
tags:
Forest Labs, kickbacks, antidepressants, Celexa, Lexapro
Hospital Says Astellas Is A Monopolistic Bully
Pharmalot
Friday, September 17, 2010 - 11:49am
tags:
hospitals, Astellas, Adenoscan
Drugs, Drugs Everywhere: CRXL Soars, ARNA Plunges
Barron's
Friday, September 17, 2010 - 11:47am
tags:
Arena Pharmaceuticals, FDA, JNJ, Crucell, M&A
J&J and P&G Stock: Bearish or Bullish?
TheStreet.com
Friday, September 17, 2010 - 11:10am
tags:
P&G, JNJ
Optimer's Fidaxomicin Encourages
Yahoo/Zacks.com
Friday, September 17, 2010 - 11:09am
tags:
Optimer, fidaxomicin, Clostridium Difficile
Why AEterna Zentaris Is Worth Double
Seeking Alpha
Friday, September 17, 2010 - 11:06am
tags:
Aeterna Zentaris, Keryx, Shionogi, Spectrum Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.